First Time Loading...

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.451 USD 4.57% Market Closed
Updated: May 2, 2024

Redhill Biopharma Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Redhill Biopharma Ltd
Cash from Operating Activities Peer Comparison

Comparables:
T
TEVA
TARO
I
INCR
MDWD
R
REKA

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Redhill Biopharma Ltd
NASDAQ:RDHL
Cash from Operating Activities
-$26.2m
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
-12%
T
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash from Operating Activities
$1.4B
CAGR 3-Years
4%
CAGR 5-Years
-11%
CAGR 10-Years
-8%
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Cash from Operating Activities
$142.9m
CAGR 3-Years
48%
CAGR 5-Years
-17%
CAGR 10-Years
-9%
I
InterCure Ltd
TASE:INCR
Cash from Operating Activities
-₪3.4m
CAGR 3-Years
40%
CAGR 5-Years
-27%
CAGR 10-Years
-2%
Mediwound Ltd
NASDAQ:MDWD
Cash from Operating Activities
-$10.5m
CAGR 3-Years
-15%
CAGR 5-Years
3%
CAGR 10-Years
-1%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Operating Activities
₪30.7m
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
15%

See Also

What is Redhill Biopharma Ltd's Cash from Operating Activities?
Cash from Operating Activities
-26.2m USD

Based on the financial report for Dec 31, 2023, Redhill Biopharma Ltd's Cash from Operating Activities amounts to -26.2m USD.

What is Redhill Biopharma Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-12%

Over the last year, the Cash from Operating Activities growth was 10%. The average annual Cash from Operating Activities growth rates for Redhill Biopharma Ltd have been 19% over the past three years , 5% over the past five years , and -12% over the past ten years .